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Causes and management of diarrhoea  
in children in a clinical setting
Diarrhoeal disease and its complications remain a major cause of 
morbidity and mortality in children, especially in developing countries. 
It is the second most common cause of death in children under five 
years of age worldwide and is responsible for 2.4 million deaths 
each year.1 The Medical Research Council Burden of Disease report 
indicates that in South Africa, it is the third biggest killer of children 
under five, responsible for over 10 000 deaths annually(10.2% of total 
deaths).2 There are approximately 1.5 billion episodes of diarrhoea 
per year so knowledge of aetiology and appropriate management is 
essential for all health care practitioners. The most recent advances 
in the area of acute diarrhoeal disease include zinc supplementation, 
reduced osmolarity oral rehydration solution (ORS) and rotavirus 
vaccination.
Definitions
Diarrhoea is characterised by an increased frequency and volume, 
and decreased consistency of stool from the norm. It must be 
remembered that frequency of passing stool varies with age and is 
higher in infants.4 Dysentery is defined as the passage of blood and 
mucous in diarrhoeal stools. Persistent diarrhoea occurs when the 
duration of symptoms exceeds seven days and chronic diarrhoea 
when it lasts more than 14 days.4,5
Causes of diarrhoea
The commonest causes of infectious diarrhoea are shown in Table I.
The incidence of these pathogens varies between developed and 
developing world settings. In developed countries about 70% of 
diarrhoea cases are of viral (40% rotavirus),10–20% of bacterial and 
< 10% of protozoal origin.3.5.6,7 In developing countries 50–60% of 
cases are of bacterial (Enteropathogenic E. Coli 25%, Campylobacter 
jejuni 10–18%, Shigella spp and Salmonella spp 5% each), 35% of 
viral(15–25% rotavirus) origin, and in many the cause is unidentified 
or mixed.3.5.6,7,8 In developing countries the prevalence of diarrhoea 
also varies widely by country. For instance, there are many more 
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cases of cholera in India and South east Asia, whilst in Africa 
rotavirus has been shown to be the causative agent in 28-49% of 
cases in Ethiopia but only 14 % of cases in Tanzania.7,8 The incidence 
of rotavirus diarrhoea varies widely even within each country with 
studies from South Africa indicating a range of 14–34% of cases in 
Johannesberg, 20–55% in Durban7 and 18% in Cape Town.9 
There is also a marked seasonality that is associated with the 
incidence of infectious childhood diarrhoea. This is best reflected 
in rotavirus infection, classically described in dry winter months in 
temperate climates.5,7,8 This is documented in studies from Durban 
and Johannesberg, but not in the summer peak of diarrhoea in Cape 
Town and other developing countries.7,9 This pattern is most likely 
due to the Mediterranean climate in Cape Town with wet winters and 
hot dry summers.
Bacterial pathogens like Campylobacter jejuni and Salmonella 
spp invade the lining of the small and large intestine and trigger 
inflammation so children tend to have higher fevers and a dysentery-
like picture. These organisms can spread systemically especially in 
young children. Shigella dysenteriae and ETEC infections can also be 
complicated by the haemolytic uraemic syndrome.5
Certain organisms are more closely associated with chronic 
diarrhoea, and these include Giardia lamblia and Cryptosporidium 
parvum.3 
Rotavirus diarrhoea is the most important aetiological agent 
worldwide implicated in severe dehydrating diarrhoea requiring 
hospitalisation. The annual burden of disease is estimated as more 
than 110 million diarrhoeal episodes, 25 million clinic visits, 2 million 
hospitalisations and 600 000 childhood deaths per year.7,8,10,11 
More than 90% of rotavirus deaths occur in developing countries. 
Improvements in water supply and sanitation have been shown to 
reduce the transmission of enteric bacteria and parasites, but do 
not appear to have a major impact on rotavirus diarrhoea, so the 
introduction of a vaccine shows the greatest promise in reducing 
the burden of disease. The peak age of infection is quoted as six 
months to two years. In developing countries, however, children 
often present younger, with the median age of hospitalisation of 
all-cause diarrhoea being nine months when compared with that of 
six months in rotavirus diarrhoea, with 97% of cases occurring in 
children younger than 18 months. Some studies indicate that up to 
38% of patients with rotavirus diarrhoea were < 6 months of age. 
A small infectious dose is required (< 100 virus particles) for the 
virus to enter the small intestinal epithelium where it elaborates a 
potent enterotoxin which damages epithelial cells causing blunted 
villi and massive viral shedding. This results in a profuse watery 
non-inflammatory diarrhoea, rapid dehydration and electrolyte 
disturbances. It is often associated with initial fever and vomiting 
for two to three days, and the course of the infection lasts two to 
seven days.8,10,11
The recent outbreak of cholera in Zimbabwe with rice-water stools 
and rapid dehydration, has highlighted the risks of the spread and 
severity of illness. A travel history is important when considering the 
aetiology of diarrhoea as management may differ, including the need 
for isolation and notification.3 When a child presents with diarrhoea, 
especially in chronic non-dehydrating diarrhoea,, noninfectious 
causes must also always be considered in the differential 
diagnosis5
  (Table II). 
The aetiologic approach in nosocomial diarrhoea will also differ as 
one needs to consider Clostridium difficile infection. This is a spore 
forming anaerobe, and patients colonised with a toxin producing 
strain can develop disease especially when treated with antibiotics. 
Rotavirus and astrovirus are other important causes of nosocomial 
diarrhoea outbreaks through the faecal-oral transmission and 
contamination of environmental surfaces.3
Although it is important to recognise the specific microbiological 
causation of diarrhoea in order to target appropriate treatment, 
the broader preventive aspects put forward by the WHO indicate 
the fundamental contributors to the massive burden of disease in 
developing countries. In a global setting where up to a quarter of 
children are malnourished, over a billion people do not have access to 
safe water and over two billion have inadequate sanitation, together 
with a low breastfeeding prevalence, social disruption from war and 
natural disasters as well as poor maternal education, the vicious 
cycle of infection, diarrhoea and malnutrition is perpetuated.3
Management 
Management of a child presenting with acute diarrhoea must include 
a thorough history and examination with evaluation of hydration 
status, nutritional status and comprehensive clinical evaluation 
for any complications or associated illnesses.4,5 A decision then 
needs to be made on method of rehydration, feeding, and if there 
are indications for any specialised investigations. Pharmacologic 
therapy is usually limited to micronutrient support.4,5
Clinical evaluation 
After obtaining a history of diarrhoea with or without vomiting, the 
first priority in initial evaluation is to identify and treat shock. The 
clinical features and initial management of shock are shown in Table 
III. These children require rapid venous access, and after the initial 
fluid bolus, a 10 ml/kg bolus should be repeated if signs of shock 
persist. Such children may also need additional general supportive 
care including oxygen and must be continuously and very intensively 
monitored.5,12
Table II: Differential diagnosis in children presenting with diarrhoea
•	 Infections	outside	the	GIT,	like	meningitis	and	urinary	tract	infection
•	 Surgical	conditions	like	intussuseption	and	malrotation,	especially	if	





bowel disease, coeliac disease
•	 Toddler’s	diarrhoea
GIT = Gastrointestinal tract
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Further history should include information on the duration and 
frequency of diarrhoea, presence of blood or mucous in the stool, 
vomiting and whether it is bile stained, use and mixing of home 
rehydration fluids, as well as other usual aspects of the paediatric 
history including past illnesses, immunisation status, feeding, 
medications and related side effects. The Integrated Management of 
Childhood Illness (IMCI) has simplified the classification dehydration 
into i) no signs of dehydration, ii) some dehydration (correlating with 
the old classification of 5% dehydration), and iii) severe dehydration 
(correlating with the old classification of 10% dehydration)12 (Table 
III),  The indications for hospitalising a child with diarrhoea are shown 
in	table	IV.
A relatively objective way of assessing dehydration is comparing 
current weight with a recently recorded weight, usually in the Road 
to Health Card (RTHC) to calculate the percentage dehydration. 
Capillary refill time, skin turgor and an abnormal respiratory pattern 
indicative of acidosis have been found by systematic review to be 
the best indicators of degree of dehydration.3,5 
Rehydration and fluid management
The observation that glucose-sodium co-transport was unaffected in 
cholera and recognition that secretory and absorptive processes in 
the intestine are separate, led to the formulation of Oral Rehydration 
Solution (ORS), with similar concentrations of sodium and glucose 
that optimise absorption together with potassium, chloride and 
bicarbonate.3 It is considered one of the most important medical 
innovations of modern times and its active promotion as part of 
the WHO Control Diarrheal Disease (CDD) programme in the 1980s 
halved the deaths from diarrhoea over 20 years following its 
implementation.1,7 
A Cochrane review has documented that oral rehydration should 
be used as the first line for management of children with acute 
gastroenteritis and some dehydration.13 When this is not feasible, 
enteral rehydration by nasogastric route is as effective, if not better, 
than	IV	rehydration	(Table	V),	with	fewer	major	adverse	events	and	
shorter hospital stay. In addition, it is cheaper in terms of both 
consumables and human resources and less traumatic for the 
child.4,5,13 
The	 WHO,	 European	 Society	 of	 Paediatric	 Gastroenterology,	
Hepatology,	 and	 Nutrition	 (ESPGHAN)	 and	 American	 Academy	 of	
Paediatrics(AAP) all recommend rapid rehydration over four hours in 
mild to moderate(IMCI “some”) dehydration. Rehydration should be 
slower over 8–24 hours in children under three months of age, those 
with respiratory or cardiac disease, those with suspected or proven 
hypernatraemia and in malnourished children.13
There has been ongoing controversy regarding the ideal composition 
of ORS. Initial WHO preparations had higher sodium concentration 
due to its development in areas with high incidence of cholera (which 
is complicated by hyponatraemia). After multiple modifications the 
current	WHO	Guidelines	recommend	a	reduced osmolarity ORS with 
lower concentrations of sodium (75 mmol/l vs 90 mmol/l) and glucose 
(75 mmol/l vs 111 mmol/). A meta-analysis has shown its safety and 
efficacy in both cholera and non-cholera diarrhoea, with lower use 
Table III: Features and management of shock and dehydration (modified from WHO and IMCI)4,5



















Usually but not always with evidence of severe 
extravascular dehydration 

















ORS = Oral Rehydration Solution
Table IV: Indications for hospitalisation4,5


















Note: Intravenous fluids should be avoided in children who are malnourished or 
with underlying cardiac or respiratory disease including associated pneumonia.
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of intravenous fluid rescue, reduced vomiting and similar rates of 
hyponatraemia when reduced osmolarity is compared with standard 
ORS.3,4,5	ESPGHAN	in	fact	recommends	an	even	lower	concentration	
of sodium of 60 mmol/l for use in children with diarrhoea in Europe 
due to the different aetiology of diarrhoea in European settings.4 
Multiple other modified formulations of ORS have also been extensively 
studied. Rice-based ORS can be used as an alternative therapy to 
standard ORS in cholera, as it adds additional substrate to the gut 
lumen without increasing osmolality, thereby providing additional 
glucose molecules for glucose-mediated absorption. However, there 
is no additional benefit in children with non-cholera diarrhoea. Other 
modifications include ORS-containing amylase-resistant starch, as it 
is postulated that the non-absorbed carbohydrates increase short-
chain fatty acids availability which enhance colonic absorption of 
sodium and water, but further trials are needed to demonstrate 
superiority. ORS has also been combined with guar gum, a mixture 
of non-digestible carbohydrates, as well as with probiotics, zinc and 
glutamine but there is currently insufficient evidence for any of their 
use bearing in mind the additional considerations of increased cost, 
instability and availability of additional compounds.4
Prevention of further dehydration by supplementing maintenance 
fluid with ORS with each loose stool to replace ongoing loses is an 
essential part of further management (50–100ml per loose stool). 
The	child’s	hydration	status	must	be	re-assessed	regularly	at	least	
every four to six hours including a weight check, and fluids modified 
according to whether there is improvement or not.5
Maintain nutrition
Consensus	 from	 WHO,	 ESPGHAN	 and	 the	 AAP	 based	 on	 level	 1	
evidence is to continue breastfeeding at all times, and to continue 
normal feeds in uncomplicated gastroenteritis within four hours. 
There is no role for dilution or gradual re-introduction of formula or 
for special formulae like soya-based or lactose free. Beverages with 
high sugar content should not be used. An extra meal a day for at 
least a week following an episode of gastroenteritis should also be 
encouraged to allow catch-up growth4,5,13.
Investigations
Testing for electrolytes should be performed on hospitalised children 
with severe dehydration or shock, those receiving intravenous fluids, 
those with associated malnutrition and in any child that looks ill out 
of proportion to their degree of dehydration.4,5 Children appearing 
floppy or with abdominal distension must have hypokalaemia 
excluded, and hypernatraemia should be suspected in well-nourished 
children, with a rubbery feel to the skin, those with a high pitched 
cry, and in any children with a history of incorrect mixing of ORS. 
Indications for sending a stool microscopy, culture and sensitivity 
(MCS) include inflammatory diarrhoea with blood and pus in the 
stool, high fever and systemic illness, persistent diarrhoea and in 
hospitalised children that develop diarrhoea, including for C. difficile. 
Routine testing for rotavirus is of epidemiologic interest but does 
not change the management of diarrhoea which is supportive. Most 
laboratories do not test for E. Coli types so the yield from stool MCS 
is low, and routine stool testing is not recommended.3,4,5
There is no role for routine full blood count and inflammatory markers 
like C-reactive protein in uncomplicated gastroenteritis but young 
children under three months and children with a high fever should 
have a formal septic workup.3,4,5
Pharmacologic therapy
Zinc deficiency is common in young children in the developing world 
and is associated with impaired electrolyte and water absorption, 
decreased brush border enzyme activity and impaired cellular 
and humoral immunity. Meta-analyses have confirmed that zinc 
supplementation reduces the duration and severity of acute and 
persistent diarrhoea and reduces the risk of a recurrent episode in the 
next 2–3 months. WHO and UNICEF recommend zinc supplementation 
(10 mg in children under six months and 20 mg in children over six 
months) for 10–14days as a universal treatment.14,15,16	 ESPGHAN	
however does not recommend it as a routine treatment modality in 
European children, unless they are malnourished.4
Probiotics may be an effective adjunct to the management of 
diarrhoea, but it is important to prescribe those that have been 
documented to be effective. Lactobacillus GG and Saccharomyces 
boulardii have the most consistently documented efficacy data. 
Best results have been demonstrated in young infants with viral 
gastroenteritis when the probiotic is administered early in the 
course of the diarrhoea, at a dose of 1010 CFU/day. The advantages 
include reduced duration of diarrhoea by one day thereby reducing 
costs of hospitalisation, reduced persistent diarrhoea and reduced 
spead through viral shedding. There are concerns however in the 
developing world regarding the use of probiotics in the management 
of diarrhoea because of the high prevalence of bacterial diarrhoea in 
such clinical settings, in which probiotcs may be less efficacious and 
safety issues related to immunosuppression may arise.4,16
Management of diarrhoea is otherwise usually supportive and 
non-pharmacologic. Antimotility agents like loperamide have been 
associated with prolonged disease in Shigellosis, toxic megacolon in 
C. difficile infection, and haemolytic-uraemic syndrome in children 
with Shiga-toxin producing E. Coli and are not recommended.3,4,5. 
The older anti-emtics are also not recommended due to risk of extra-
pyramidal side-effects but some newer agents like ondansetron are 
effective without side-effects.4,5 There is no evidence to support the 
use of prebiotics, glutamine, folic acid, kaolin-pectin, attapulgite, 
activated charcoal or bismuth. There may however be potential 
benefit in the use of smectite, an aluminmagnesium silicate that 
binds digestive mucous.4	Vitamin	A	 does	 not	 influence	 the	 course	
of acute diarrhoea but should be given according to national 
guidelines for its effect on reducing overall mortality.4 Antibiotics 
are not routinely recommended in viral or uncomplicated bacterial 
gastroenteritis (Table	VI).	
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Management of children with chronic diarrhoea
As for the child presenting with acute diarrhoea, there should be a 
thorough history, including family history, and comprehensive clinical 
evaluation including effect on nutritional status for those with chronic 
diarrhoea.17 It is important to differentiate whether this is a persistent 
diarrhoea following an acute dehydrating diarrhoeal episode, as 
causes may include small bowel bacterial overgrowth, acquired 
disaccharidase defi ciency, deconjugation and dehydroxylation of 
bile salts which induces diarrhoea, protein sensitisation i.e clinical 
settings that may require additional specialised treatment.18 The 
clinical picture of the child is also of importance since it may be 
indicative of the cause of diarrhoea such as the classic Toddler’s 
Diarrhoea with a thriving child and stools containing undigested food 
and worsening as the day progresses. The need for any specialised 
investigation and treatment will depend on the clinical picture of the 
patient and would usually include stool MC&S to exclude parasites, 
stool reducing substances and elastase, and possibly sweat test or 
coeliac serology.17
Prevention
On discharge of a child with an episode of diarrhoea, advice must be 
given on measures to try to prevent another episode and appropriate 
home management to prevent dehydration. 
The WHO Enhanced Diarrhoeal Disease Control (EDDC) focuses on a 
combination of public health issues like handwashing, preparation 
and storage of food as well as drinking water and sanitation; 
promotion of breastfeeding (which affords a six-fold protection); zinc 
supplementation and rotavirus vaccines.1 The enormous burden of 
rotavirus disease has been mentioned and vaccine introduction in 
developing countries is thought to have the potential to save 600 
000 children’s lives per year and help towards the achievement of 
the Millenium Development Goal of reducing childhood mortality by 
2/3 by 2015.1,8 Rotarix has been licensed in South Africa since 2006 
and was introduced in the Extended Programme of Immunisation in 
2009. It is a live attenuated human rotavirus strain, with two doses 
given orally foour weeks apart, not after six months. In studies in 
middle-income countries the vaccine has a very good safety profi le 
and effi cacy of 85% protection. There are some concerns though 
about its use in the developing world. Such concerns include 
interference by high titres of maternal antibodies, interference by 
gut microorganisms as well as safety and immunogenicity in HIV-
infected children. Nevertheless, the vaccine holds promise as an 
extremely important and much needed public health intervention 
to reduce the signifi cant morbidity and mortality from diarrhoeal 
disease.8,10,11
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Table VI: Indications for systemic antibiotics. 
Indications Antibiotic regimen
• Bacterial gastroenteritis 
complicated by sepsis
• Neonates
• Ill immunocompromised children
• Associated infection e.g. urinary 




• Salmonella spp (non-typhoid)
• Campylobacter 





• Vibrio cholera if complicated by 
severe dehydration
• C. diffi cile
• Usually ampicillin and gentamicin OR 
ceftriaxone
• Nalidixic acid, fl uoroquinolone or 
ceftriaxone
• Erythromycin or one of above
• Metronidazole
• Metronidazole
• Doxycycline(> 6 years) or fl uoroquinolone
• Metronidazole or oral vancomycin
ETEC = Enterotoxigenic E. Coli, HUS = Haemolytic Uraemic Syndrome
